公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2019 | Prevalence of overactive bladder in China, Taiwan and South Korea: Results from a cross-sectional, population-based study | Chuang Y.-C.; SHIH-PING LIU ; Lee K.-S.; Liao L.; Wang J.; Yoo T.K.; Chu R.; Sumarsono B. | LUTS: Lower Urinary Tract Symptoms | 75 | 60 | |
1999 | The prevalence of sharps injury, blood and body fluids exposure among emergency department staffs in Taiwan | Hung M.-C.; JUDITH SHU-CHU SHIAO ; Chuang Y.-C.; Huang K.-Y.; Yue Leon Guo | Chinese Journal of Public Health | 2 | | |
2020 | The prevalence of urinary incontinence in men and women aged 40 years or over in China, Taiwan and South Korea: A cross-sectional, prevalence-based study | Sumarsono B.; Jong J.J.; Wang J.-Y.; Liao L.; Lee K.-S.; Yoo T.K.; SHIH-PING LIU ; Chuang Y.-C. | LUTS: Lower Urinary Tract Symptoms | 12 | 9 | |
2016 | Prevalence of vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA among methicillin-resistant S. aureus with high vancomycin minimal inhibitory concentrations in Taiwan: A multicenter surveillance study, 2012–2013 | Huang S.-H.; YEE-CHUN CHEN ; Chuang Y.-C.; Chiu S.-K.; Fung C.-P.; Lu P.-L.; Wang L.-S.; Wu T.-L.; JANN-TAY WANG | Journal of Microbiology, Immunology and Infection | 29 | 20 | |
2006 | Prognostic factors and antibiotics in Vibrio vulnificus septicemia | Liu J.-W.; Lee I.-K.; Tang H.-J.; Ko W.-C.; Lee H.-C.; Liu Y.-C.; PO-REN HSUEH ; Chuang Y.-C. | Archives of Internal Medicine | 78 | 73 | |
2020 | A prospective, multicenter, noninterventional study in Taiwan to evaluate the safety and tolerability of lacosamide as adjunctive therapy for epilepsy in clinical practice | Wu T.; Chuang Y.-C.; Huang H.-C.; Lim S.-N.; Hsieh P.F.; WANG-TSO LEE ; Cheng M.-Y.; Tsai M.-H.; Jou S.-B.; Chang C.-W.; Hsieh H.-Y.; Du X.; Hellot S.; McClung C.; Hung C. | Epilepsy and Behavior | 4 | 4 | |
2012 | Pyridoxamine ameliorates the effects of advanced glycation end products on subtotal nephrectomy induced chronic renal failure rats | Chuang Y.-C.; MING-SHIOU WU ; Wu T.-H.; Su Y.-K.; Lee Y.-M. | Journal of Functional Foods | 6 | 6 | |
2019 | Recommendations and guidelines for the treatment of pneumonia in Taiwan | Chou C.-C.; Shen C.-F.; Chen S.-J.; Chen H.-M.; Wang Y.-C.; Chang W.-S.; Chang Y.-T.; Chen W.-Y.; Huang C.-Y.; Kuo C.-C.; Li M.-C.; Lin J.-F.; Lin S.-P.; Ting S.-W.; Weng T.-C.; Wu P.-S.; UN-IN WU ; Lin P.-C.; Lee S.S.-J.; Chen Y.-S.; Liu Y.-C.; Chuang Y.-C.; CHONG-JEN YU ; LI-MIN HUANG ; Lin M.-C.; Infectious Diseases Society of Taiwan; Taiwan Society of Pulmonary; Critical Care Medicine,, Medical Foundation in Memory of Dr. Deh-Lin Cheng; Foundation of Professor Wei-Chuan Hsieh for Infectious Diseases Research; Education; CY Lee's Research Foundation for Pediatric Infectious Diseases; Vaccines,, The 4th Guidelines Recommendations for Evidence-based Antimicrobial agents use in Taiwan (GREAT) working group | Journal of Microbiology, Immunology and Infection | 76 | 67 | |
2019 | Resistance mechanisms and molecular epidemiology of carbapenem-nonsusceptible escherichia coli in Taiwan, 2012-2015 | Chang Y.-T.; Siu L.K.; JANN-TAY WANG ; Wu T.-L.; Chen Y.-H.; Chuang Y.-C.; Lin J.-C.; Lu P.-L. | Infection and Drug Resistance | 22 | 21 | |
2016 | RNA polymerase B subunit gene mutations in?biofilm-embedded methicillin-resistant Staphylococcus aureus following rifampin treatment | Tang H.-J.; Lai C.-C.; PO-REN HSUEH ; Chen C.-C.; Wu K.-Y.; Lin Y.-C.; Zhang C.-C.; Weng T.-C.; Chiu Y.-H.; Toh H.-S.; Chiang S.-R.; Yu W.-L.; Ko W.-C.; Chuang Y.-C. | Journal of Microbiology, Immunology and Infection | 9 | 9 | |
2016 | Schoolchildren's antioxidation genotypes are susceptible factors for reduced lung function and airway inflammation caused by air pollution | Chen B.-Y.; CHI-HSIEN CHEN ; Chuang Y.-C.; Kim H.; Honda Y.; Chiang H.-C.; Yue Leon Guo | Environmental Research | 13 | 11 | |
2000 | Scleral buckling for stage 4 retinopathy of prematurity | Chuang Y.-C.; CHUNG-MAY YANG | Ophthalmic Surgery and Lasers | 27 | 15 | |
2011 | Seroprevalence and severity of 2009 pandemic influenza a H1N1 in Taiwan | Chen C.-J.; PING-ING LEE ; SHAN-CHWEN CHANG ; Huang Y.-C.; Chiu C.-H.; Hsieh Y.-C.; Chang F.-Y.; Lee J.-J.; Su S.-C.; Shen G.-H.; Chuang Y.-C.; Chen Y.-S.; Liu J.-W.; Lin T.-Y. | PLoS ONE | 21 | 15 | |
2003 | Telithromycin and quinupristin-dalfopristin resistance in clinical isolates of Streptococcus pyogenes: SMART program 2001 data | PO-REN HSUEH ; LEE-JENE TENG ; Lee C.-M.; Huang W.-K.; Wu T.-L.; Wan J.-H.; Yang D.; Shyr J.-M.; Chuang Y.-C.; Yan J.-J.; Lu J.-J.; Wu J.-J.; Ko W.-C.; Chang F.-Y.; Yang Y.-C.; Lau Y.-J.; Liu Y.-C.; Leu H.-S.; Liu C.-Y.; KWEN-TAY LUH | Antimicrobial Agents and Chemotherapy | 32 | 26 | |
2003 | Telithromycin- and fluoroquinolone-resistant Streptococcus pneumoniae in Taiwan with high prevalence of resistance to macrolides and β-lactams: SMART program 2001 data | PO-REN HSUEH ; LEE-JENE TENG ; Wu T.-L.; Yang D.; Huang W.-K.; Shyr J.-M.; Chuang Y.-C.; Wan J.-H.; Yan J.-J.; Lu J.-J.; Wu J.-J.; Ko W.-C.; Chang F.-Y.; Yang Y.-C.; Lau Y.-J.; Liu Y.-C.; Lee C.-M.; Leu H.-S.; Liu C.-Y.; KWEN-TAY LUH | Antimicrobial Agents and Chemotherapy | 36 | 34 | |
2020 | Tigecycline therapy for infections caused by extended-spectrum β-lactamase-producing enterobacteriaceae in critically ill patients | Yu W.-L.; Lee N.-Y.; JANN-TAY WANG ; Ko W.-C.; Ho C.-H.; Chuang Y.-C. | Antibiotics | 5 | 2 | |
2018 | Treatment outcome of non-carbapenemase-producing carbapenem-resistant Klebsiella pneumoniae infections: a multicenter study in Taiwan | Su C.-F.; Chuang C.; Lin Y.-T.; Chan Y.-J.; Lin J.-C.; Lu P.-L.; Huang C.-T.; JANN-TAY WANG ; Chuang Y.-C.; Siu L.K.; Fung C.-P. | European Journal of Clinical Microbiology and Infectious Diseases | 23 | 21 | |
2012 | Trends in susceptibility of vancomycin-resistant Enterococcus faecium to tigecycline, daptomycin, and linezolid and molecular epidemiology of the isolates: Results from the Tigecycline in Vitro Surveillance in Taiwan (TIST) study, 2006 to 2010 | Tsai H.-Y.; Liao C.-H.; Chen Y.-H.; Lu P.-L.; Huang C.-H.; Lu C.-T.; Chuang Y.-C.; Tsao S.-M.; Chen Y.-S.; Liu Y.-C.; Chen W.-Y.; Jang T.-N.; Lin H.-C.; Chen C.-M.; Shi Z.-Y.; SUNG-CHING PAN ; Yang J.-L.; HSIANG-CHI KUNG ; Liu C.-E.; Cheng Y.-J.; Liu J.-W.; Sun W.; Wang L.-S.; Ko W.-C.; Yu K.-W.; Chiang P.-C.; Lee M.-H.; Lee C.-M.; Hsu G.-J.; PO-REN HSUEH | Antimicrobial Agents and Chemotherapy | 20 | 19 | |
2013 | Trends in the antimicrobial susceptibilities and serotypes of Streptococcus pneumoniae: Results from the Tigecycline in Vitro Surveillance in Taiwan (TIST) study, 2006-2010 | Tsai H.-Y.; Chen Y.-H.; Liao C.-H.; Lu P.-L.; Huang C.-H.; Lu C.-T.; Chuang Y.-C.; Tsao S.-M.; Chen Y.-S.; Liu Y.-C.; Chen W.-Y.; Jang T.-N.; Lin H.-C.; Chen C.-M.; Shi Z.-Y.; SUNG-CHING PAN ; Yang J.-L.; HSIANG-CHI KUNG ; Liu C.-E.; Cheng Y.-J.; Liu J.-W.; Sun W.; Wang L.-S.; Ko W.-C.; Yu K.-W.; Chiang P.-C.; Lee M.-H.; Lee C.-M.; Hsu G.-J.; PO-REN HSUEH | International Journal of Antimicrobial Agents | 11 | 11 | |
2012 | Trends in the susceptibility of clinically important resistant bacteria to tigecycline: Results from the tigecycline In Vitro surveillance in Taiwan study, 2006 to 2010 | Chen Y.-H.; Lu P.-L.; Huang C.-H.; Liao C.-H.; Lu C.-T.; Chuang Y.-C.; Tsao S.-M.; Chen Y.-S.; Liu Y.-C.; Chen W.-Y.; Jang T.-N.; Lin H.-C.; Chen C.-M.; Shi Z.-Y.; SUNG-CHING PAN ; Yang J.-L.; HSIANG-CHI KUNG ; Liu C.-E.; Cheng Y.-J.; Liu J.-W.; Sun W.; Wang L.-S.; Ko W.-C.; Yu K.-W.; Chiang P.-C.; Lee M.-H.; Lee C.-M.; Hsu G.-J.; PO-REN HSUEH | Antimicrobial Agents and Chemotherapy | 39 | 35 | |